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Summary The incidence of breast cancer among 1240 women who were treated surgically for breast
hypertrophy in Copenhagen, Denmark between 1943 and 1971 was determined and compared with age- and
calendar period-specific rates for the Danish female population. A total of 32 cases of breast cancer had
developed by the end of 1990; the expected number was 52.55, yielding a relative risk (RR) of 0.61 [95%
confidence interval (CI) 0.42-0.86]. The greatest reduction in risk was observed for women who had 600 g or
more of breast tissue removed (RR=0.30; 95% CI 0.10-0.69). This suggests that the number ofpotential foci
is important for cancer development in the female breast. In the group of women who were operated on before
the age of20, four cases ofbreast cancer developed, compared with 2.23 expected cases, to give an RR of 1.79,
suggesting that the aetiology of their breast hypertrophy may be different from that for the rest of the group.
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As women with breast hypertrophy may have their breasts
surgically reduced, the natural question is whether this
operation influences their risk for breast cancer. Animal
experiments have suggested that the damage to the mammary
ducts caused by mammoplasty leads to the evolution of stasis
and hence to cancer (Fekete and Green, 1936). It has also
been suggested, however, that surgical reduction of the breast
decreases the incidence of breast cancer by reducing the
number of potential foci for cancer development (Str6mbeck,
1964; Rees and Coburn, 1972).
This study is a second follow-up of a cohort originally
studied by Lund et al. (1987), comprising 1283 women
operated on for breast hypertrophy between 1 January 1943
and 31 August 1971, who were followed up to 31 December
1982. The original study found a reduced incidence of breast
cancer among these women in comparison with the Danish
female population. The cohort has now been followed up to
31 December 1990.
Materials and methods
The study group consisted of all women with breast
hypertrophy treated by reduction mammoplasty at five
surgical departments in Copenhagen, Denmark, between 1
January 1943 and 31 August 1971, and three patients operated
on before 1 January 1943. The material was collected by
examining diagnostic indices and lists of operations. The
hospital records of 31 patients could not be located and these
patients were excluded from the analysis. In the first study five
patients were included twice in the study population, which
therefore consisted of 1278 women. Six patients were lost to
follow-up; in our follow-up, one patient was excluded as she
appeared to have died before the operation. Thus, our study
group consisted of 1240 patients. Information was obtained
fromhospital records on age, county, type ofsurgical technique
and amount ofremoved tissue.
Several surgical techniques were used: the reduction was
bilateral in 1201 cases, right-sided in 24 cases, and left-sided
in 15 cases. The amount of tissue removed was unknown for
36 patients.
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On the basis of the patient's personal identification
number or, if this was lacking, the patient's name and date
of birth, the Central Population Register was consulted for
date of death or emigration. Cases of breast cancer were
identified by cross-linkage with the Danish Cancer Register.
The period of follow-up was from the time of reduction
mammoplasty to the first of the following events: time of
breast cancer diagnosis, death, emigration or 31 December
1990. The three women operated on before 1943 were
followed from 1 January 1943 because information on
breast cancer incidence in the population was lacking before
that date.
The relative risk was calculated as the observed number of
breast cancer cases divided by the expected number. The
expected number of breast cancers was obtained by multi-
plying the years at risk in 5 year age groups and calendar
year periods by the breast cancer rate for the Danish female
population. Ninety-five per cent confidence intervals were
calculated using Byar's formula (Breslow and Day, 1987).
Multiplicative Poisson regression models were used to
investigate further possible risk factors such as calendar
year, age and place of residence at the time of operation for
breast hypertrophy, type of operation, surgical department,
latency time (time since operation) and age at diagnosis of
breast cancer. The Epicure program (Preston et al., 1993) was
used in the analyses.
Results
In our study group of 1240 women operated on for breast
hypertrophy, 32 cases of breast cancer were diagnosed,
whereas 52.55 cases were expected if their risk was the same
as that of the general population. This yielded a relative risk
(RR) of 0.61 (95% CI 0.42-0.86) (see Table I).
We also looked at the risk of breast cancer on the basis of
how much breast tissue was removed from the breast with the
greatest reduction: <400 g, 400-600 g or >600 g. The 367
women with more than 600 g of tissue removed had a
significantly lower risk than the general population
(RR=0.30; 95% CI 0.10-0.69) at all time intervals after
operation (latency). In addition, Table I shows how the RR
varies with latency time. There appears to be a sharp drop in
the RR 10-19 years after operation and an increaseBreast cancer risk after breast reduction
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Table I Relative risk ofbreast cancer for 1240 women with surgical reduction ofbreasts, operated on in Copenhagen, 1943-71, and followed
until 1990 by latency and amount of breast tissue removed
Amount of breast Number of cases
Time after operation tissue removed Number
(years) (g) of women Obs Exp RR 95% CI
All Missing 36 0 1.35 - -
<400 468 15 18.65 0.80 0.45-1.33
400-599 369 12 15.63 0.77 0.40-1.34
>600 367 5 16.93 0.30 0.10-0.69
Total 1240 32 52.55 0.61 0.42-0.86
0-9 <400 2 2.47 0.81 0.09-2.92
400-599 2 2.05 0.98 0.11-3.53
>600 1 2.46 0.41 0.01-2.27
Total 5 7.16 0.70 0.22-1.63
10-19 <400 2 5.30 0.38 0.04-1.36
400-599 0 4.08 -
>600 2 4.46 0.45 0.05-1.62
Total 4 14.24 0.28 0.08-0.72
20-29 <400 6 5.44 1.10 0.40-2.40
400-599 4 4.83 0.83 0.22-2.12
>600 1 5.28 0.19 0.00-1.05
Total 11 15.91 0.69 0.34-1.24
>30 <400 5 5.44 0.92 0.30-2.14
400-599 6 4.67 1.29 0.47-2.80
>600 1 4.72 0.21 0.00-1.18
Total 12 15.23 0.79 0.41-1.38
Obs, observed; Exp, expected; RR, relative risk (Obs/Exp); 95% CI, 95% confidence interval.
afterwards. However, these results are highly dependent on
the chosen latency time intervals, especially the limit between
the first two intervals.
Table II shows the relative risks and confidence intervals
stratified by age at the time of operation, corrected for the
amount of tissue removed. The 36 women with an unknown
amount of breast tissue removed were excluded in this
analysis. Table II shows that the women aged 20 years or less
at the time of the operation had a substantially (although not
significantly) higher relative risk for breast cancer in
comparison both with the general population and the other
age groups. No significant variation in breast cancer risk was
seen with type of operation, calendar year or place of
operation, residence at the time of operation, or age at breast
cancer diagnosis.
Discussion
The risk for breast cancer decreases with the amount of
breast tissue removed. This supports the hypothesis that
potential foci for breast cancer are removed by the surgery.
Table I shows that the risk is mainly reduced 10-19 years
after the operation. A reduced risk would be expected in the
first 10 years after the operation, if undiagnosed breast
cancers were removed during the operation, and not 10-19
years later, as a breast cancer is considered to take at least 10
years to become clinically perceivable. An explanation for the
increasing relative risk 20 years after the operation may be
that the patients are still influenced by factors essential to the
development of breast cancer.
The aetiology of breast hypertrophy for young women
(<21 years) may differ from that for older women. Young
women operated on for breast hypertrophy are often slim
with large breasts, whereas the older women in general tend
to be obese. This difference in aetiology could explain the
increased risk among young women.
As breast cancer is usually located in the upper lateral
quadrant of the breast, one might expect that surgical breast
reduction in which tissue was removed from this area would
lead to a further reduction in the breast cancer risk.
However, as in most of the types of operations tissue is
removed from the middle of the breast, our data are too few
to investigate this hypothesis.
The hospital records did not contain consistent informa-
tion on the distribution of known risk factors for breast
cancer, such as high social class (Ewertz, 1988), nulliparity,
high age at the time of first birth (Ewertz et al., 1990; Adami
Table II Risk for breast cancer (RR1) relative to the Danish female population by age at operation, and relative risk (RR2) standardised for
amount of breast tissue removed.
Age at operation
(years) Number Cumulative number Obs Exp RR, 95% CI RR2 95% CI
<21 132 132 4 2.23 1.79 0.48-4.59 2.78 0.85-9.03
21-30 434 566 9 13.15 0.68 0.31-1.30 la
31 -40 292 858 11 15.00 0.73 0.37-1.31 1.07 0.44-2.57
41 -50 239 1097 5 14.86 0.34 0.11-0.79 0.54 0.18-1.63
>50 107 1204 3 7.28 0.41 0.08-1.20 0.70 0.19-2.60
RR,, Obs/Exp; RR2, relative risk in multiplicative Poisson model; aReference category.
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et al., 1990), early menarche, late menopause, adult height,
hereditary characteristics (Adami et al., 1990) or hormone
treatment (Adami et al., 1990; Colditz et al., 1995). We have
no reason to believe, however, that the study population
differs from the standard population in these respects.
The missing information on the 31 patients without
hospital records and for the six women lost to follow-up
does not seem to relate to breast cancer risk. At the first
follow-up (1983), none of the 31 patients without hospital
records had breast cancer.
Some of the women operated on for breast hypertrophy
were probably obese, and as obese women have an increased
risk for breast cancer (Adami et al., 1990) the study group
should have a further decreased risk compared with obese
women. Obese premenopausal women, however, have a
decreased risk for breast cancer, possibly because of reduced
ovarian activity (Adami et al., 1990).
No studies evaluating the risk of breast cancer for women
with breast hypertrophy could be found, but Hsieh and
Trichopoulos (1991) found that the size of the breast is a risk
factor for breast cancer for post-menopausal women, even
after correction for obesity. As our study group is
characterised by large breasts, the relative risk would have
been further reduced compared with women with large
breasts without reduction mammoplasty. Our study popula-
tion contains a preponderance of women from Copenhagen
and its suburbs, where there is a slightly higher breast cancer
risk than in the rest of Denmark. Hence, the expected
number of cancer cases was too low (up to 15%), compared
with Copenhagen women.
In conclusion, the women in this study experienced a lower
risk of breast cancer than the Danish female population. The
study therefore does not support the hypothesis that damage
to the mammary ducts due to the operation increases the risk
for cancer. On the contrary, this study indicates that
reduction mammoplasty decreases the incidence of breast
cancer and that the decrease is larger the more breast tissue
removed.
Acknowledgements
Many thanks to Marianne Ewertz and Geert Schou, who assisted
us with invaluable advice.
References
ADAMI H-O, ADAMS G, BOYLE P, EWERTZ M, LEE NC, LUND E,
MILLER AB, OLSSON H, STEEL M, TRICHOPOULOS D AND
TULINIUS R. (1990). Breast-cancer etiology. Int. J. Cancer, Suppl
5, 22-39.
BRESLOW NE AND DAY NE. (eds) (1987). Statistical Methods in
Cancer Research. Vol II. The Design and Analysis of Cohort
Studies. IARC Scientific Publication No. 82. pp. 69-71.
International Agency for Research on Cancer: Lyon.
COLDITZ GA, HANKINSON SE, HUNTER DJ, WILLETT WC,
MANSON JE, STAMPFER MJ, HENNEKENS C, ROSNER B AND
SPEIZER FE. (1995). The use ofestrogens and progestins and the
risk ofbreast cancer in postmenopausal women. N. Engl. J. Med.,
332, 1589-1593.
EWERTZ M. (1988). Risk ofbreast cancer in relation to social factors
in Denmark. Acta Oncol., 27, 787-793.
EWERTZ M, DUFFY SW, ADAMI H, KvALE G, LUND E, MEIRIK 0,
MELLEMGAARD A, SOINI I AND TULINIUS H. (1990). Age at
first birth, parity, and risk of breast cancer: A meta-analysis of 8
studies from the Nordic countries. Int. J. Cancer, 46, 597-603.
FEKETE E AND GREEN CV. (1936). The influence of complete
blockage of the nipple on the incidence and location of
spontaneous mammary tumors in mice. Am. J. Cancer, 27,
513-515.
HSIEH C-C AND TRICHOPOULOS D. (1991). Breast size, handedness
and breast cancer risk. Eur. J. Cancer, 27, 131-135.
LUND K, EWERTZ M AND SCHOU G. (1987). Breast cancer incidence
subsequent to surgical reduction of the female breast. Scand. J.
Plast. Reconstr. Surg., 21, 209-212.
PRESTON DL, LUBIN JH, PIERCE DA AND MCCONNEY ME. (1993).
Epicure. Hirosoft International: Seattle.
REES TD AND COBURN R. (1972). Breast reduction: Is it an aid to
cancer detection? Br. J. Plast. Surg., 25, 144.
STROMBECK JO. (1964). Macromastia in women and its surgical
treatment. Acta Chir. Scand., Suppl 341, 111-112.